Sentences with phrase «reducing development time»

Basing product development on requirements that can be shared transparently via an integrated single source of the truth across the organization allows each stakeholder insight into how their role affects the process — encouraging collaboration, controlling costs and reducing development time.

In conclusion, eLearning templates offer more benefits than just reducing development time and effort.

Our clients quickly and easily make production quality samples, reducing development time.

«By means of this programme we have been able to reduce the development time, and our products therefore reach the market sooner.

Proposed projects must demonstrate the potential for lower cost alternatives to existing materials, the potential for energy savings, and / or the potential for reduced development time and time to market.

The publisher has said we'll now see three or four titles from series like Resident Evil and Monster Hunter as a result reducing development times.

Use a rapid eLearning authoring tool that features serious game templates to reduce development time and cost.

eLearning storyboards also reduce development time, since you won't already have a springboard to start with.

The access to these assets can reduce your development time significantly.

This reduces development time and learning costs.

This reduces both development time and costs.

A possibility to reduce development time and tie the stories all together would be to have players revisit certain landmark dungeons following different critical paths, with perhaps later groups going through seeing the aftermath of the actions of previous characters.

This reduced our development time significantly.

«So most any effort to improve the compatibility and integration of Linux distros and Windows environments can be beneficial,» he said, «and hopefully reduce development time and complexity requirements.»

Directed and delegated tasks to team members, and ensured a successful on - budget completion of the project, which reduced development time for future requirement changes and increased application efficiency, scalability, interoperability, and usability.

Responsible for driving technical enhancements where necessary to reduce development time and improve profitability

Defined Coding Standards, Best Practices, code review guidelines that reduced development time and defects.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

First, advances in computational biology, bioinformatics and artificial intelligence are permanent features helping reduce the time and cost of drug development.

The CRO industry is undergoing a wave of consolidation as pharmaceutical companies strive to cut costs, reduce clinical trial times and expand their research and development presence.

We see this as a positive development for issuers that will hopefully result in reduced financial cost and management time spent on the listing, so the resources can be focused on running the business.»

Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In March the budget featured, for the first time, a chapter on natural - resource development and included language about reducing environmental protection, penalizing environmental groups that tried to meddle in resource extraction, and speeding the approval of big resource projects.

My conclusion is that developments in the global economy during the past 50 years have greatly reduced the economic disadvantages of small nations enumerated for his time by Hamilton.

Those controls reduced the scale of projects from gigawatts to megawatts and development times from decades to years.

Free cloud computing resources from CANARIE help Canadian entrepreneurs reduce time and cost of product development

CONCLUSION: While this topic was not covered on TSLA's 1Q18 conference call last night (our analysis on this call will be published shortly), given Autopilot is among the main key drivers of TSLA's current valuation, and the «Autopilot was found by the U.S. government to reduce crash rates by as much as 40 %» line has been used by TSLA time - and - time again, we feel this development could prove more important than the company's earnings conference call yesterday.

After drawing out how the encyclical applies this to various social, economic and ecological issues he highlighted, concerning «the problem of technology», that «this is the first time an encyclical deals with the subject in such an organic manner -LSB-...] The exclusively technical mentality [and ideology] in fact, reduces all to pure doing... [True human development] requires a new perspective upon man that only the God who is truth and love can provide.»

Is there one continuous thread of development throughout human history — sometimes reduced to a trickle, at other times increasing in volume — that shapes the destiny of man for good or evil?

These structure design tools help shorten the packaging development time frame by reducing the number of physical iterations:

Tekpak's Business Development Director, Imelda Kehoe says: «Automating the off - line / WIP (work in progress) operation is a major benefit for our customers because it reduces product lead time and can have a big impact on line efficiency.»

Blue Box Design managing director Duncan Robertson said, «This new facility will greatly improve «speed to market» for our customers by reducing the packaging development cycle time from concept to delivery, thereby delivering production efficiencies and cost savings.

A new Australian study finds that parents who can get their child to follow a physical activity skill development program and modify their diet can reduce their overweight child's screen time by nearly one hour per day.

Housing and Urban Development conjointly offers First Time Home Buyer an chance to shop for homes that are foreclosed or would like rehabilitation, at a greatly reduced rate.

To reduce a baby's exposure, mothers can change their diets during pregnancy and breastfeeding, limiting the exposure to these chemicals during the critical times of growth and development.

Many times, when you begin the weaning process, your breasts may become engorged with milk as your body adjusts to your child's development and makes changes to reduce the amount of milk production over time.

Sometimes, well - meaning friends or family have the opinion that babywearing impedes baby's development by reducing tummy time.

To minimize the development of flat spots on the back of baby's head, reduce the amount of time that your babies spend lying in car seats, carriers and bouncers while they're awake.

Tummy time is important for babies both to reduce positional plagiocephaly, the flat heads often seen on babies since it's now recommended that they sleep on their backs, and to promote the development of gross motor and fine motor skills.

Parenting Pointers - Parents Matter Most 5 Essential pointers to keep kids connected and safe, including how to Problem - Solve Aim for Balance and Health 7 Keys for a balanced life 6 Warning signs of obsession Parents Fears and Childrens Needs 8 Fears of parents and 8 needs of children Safety First Entertainment Software Ratings Board (ERSB) Codes 16 Cyber-safety recommendations Benefits of Internet and Gaming 20 Academic, social and life - skill benefits of internet and video / computer games Part Two Teaching Digital Intelligence Babies and Toddlers 0 - 2 yrs Brain Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, and Experiential Learning Preschoolers 3 - 5 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, Learning Styles, Acknowledging Feelings, Advertising, and Virtual Worlds School - Agers 6 - 12 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, Sibling Fighting, Online Learning, Inactivity, Overeating, Cyber-bullying, Netiquette, Critical Thinking, Surveillance Programs and Luring Protection Teenagers 13 - 19 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, One - time Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtuTime, and Experiential Learning Preschoolers 3 - 5 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, Learning Styles, Acknowledging Feelings, Advertising, and Virtual Worlds School - Agers 6 - 12 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, Sibling Fighting, Online Learning, Inactivity, Overeating, Cyber-bullying, Netiquette, Critical Thinking, Surveillance Programs and Luring Protection Teenagers 13 - 19 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, One - time Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtuTime, Learning Styles, Acknowledging Feelings, Advertising, and Virtual Worlds School - Agers 6 - 12 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, Sibling Fighting, Online Learning, Inactivity, Overeating, Cyber-bullying, Netiquette, Critical Thinking, Surveillance Programs and Luring Protection Teenagers 13 - 19 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, One - time Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtuTime, Sibling Fighting, Online Learning, Inactivity, Overeating, Cyber-bullying, Netiquette, Critical Thinking, Surveillance Programs and Luring Protection Teenagers 13 - 19 yrs Development, Usage, Parents Role, Safety Tips, How to Reduce Screen Time, One - time Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtuTime, One - time Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtutime Consultation, Sharing Values, Boundaries, and Online Learning Be a Part of Their World The most important gift that children need and can not be provided virtually

AND science shows that less daily time in baby equipment is better for development and reduces baby's risks of Flat Head Syndrome / Positional Plagiocephaly and Torticollis (neck tightness).

in what seems to be an enciuraging development in the state, the commissioner, therefore, called on stakeholders to join hands with government in a bid to reduce emergency response time while also urging Lagosians to explore the limitless opportunities available on the platform of the State Command and Control Centre and continue to call the emergency toll free lines — 767 and 112 for distress calls.

Kellogg said that for her and her running mates, the big challenges facing Hurley are, «Making a change in our local government, protecting the quality of life that we have in Hurley as development pressures move up the Thruway, protecting our water and the beautiful scenic qualities of our town, and maintaining our low tax rates as NYS mandates additional responsibilities to the localities without providing funding (at the same time that they cap our annual budget increases) and as we get additional pressures from New York City to reduce their tax contributions for the reservoir property.»

Most scientists argue we know nothing new or compelling about the development of foetuses, and therefore have no objective grounds to reducing the abortion time limit.

Specifically, the researchers found that a peptide, called STAT6 - IP, when delivered to the lungs of neonatal mice at the time of first RSV exposure reduces the development of allergic - type lung inflammation and airway hyperresponsiveness («twitchy» airways) in mice when they are «re-challenged» with RSV as young adults.

«We are confident that the new streamlined process both dramatically reduces wait times and maintains the same level of security,» Stephen Heifetz, deputy assistant secretary for policy development at the Department of Homeland Security, told ScienceInsider.

Overhunting in the 19th and 20th centuries coupled with deforestation from increased development in modern times has reduced its population to historic lows.

Other devices and therapies in development include an implanted microchip, electrical stimulation therapy, implantable capsules of timed - release medication, nutrient therapies to reduce retinal damage and gene therapies to halt or reverse retinitis pigmentosa.

«Our ultimate goal is to engineer microbes to make new versions of these antibiotics for our use, which will drastically reduce the amount of time and money necessary for new drug testing and development,» says Gavin Williams, associate professor of bio-organic chemistry at NC State and corresponding author of a paper describing the research.